This study is looking at a new treatment called the Juveena Hydrogel System for women who experience heavy menstrual bleeding (HMB). HMB is when your period is unusually heavy and affects your daily life. The Juveena Hydrogel System is a single-use device that is placed inside the uterus as a liquid and quickly turns into a gel. Researchers want to see if it's safe and works well to temporarily control HMB. You might be able to join if you are a woman between 18 and 45 years old and have a recent history of HMB that impacts your quality of life. The main goal is to see how well the system works within 7 days after treatment. The study is currently recruiting a small number of participants.

Study design

This is a single-arm study, meaning all participants will receive the Juveena Hydrogel System. It plans to enroll 7 women.

What's involved

You will have a baseline evaluation, receive the Juveena HS treatment, and keep a diary. There will be phone calls on Days 1, 14, and 56 after treatment, and clinic visits on Day 7 and Day 28.

Compensation

Not stated in the trial record.

Follow-up

You will be followed for at least 56 days after treatment, with the primary effectiveness measured within 7 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.